𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Expression of the breast differentiation antigen NY-BR-1 in a phyllodes tumor of the vulva

✍ Scribed by Olivier T. Giger; Elena Lacoste; Christoph Honegger; Barbara Padberg; Holger Moch; Zsuzsanna Varga

Publisher
Springer
Year
2007
Tongue
English
Weight
383 KB
Volume
450
Category
Article
ISSN
1432-2307

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Distinct expression patterns of the immu
Distinct expression patterns of the immunogenic differentiation antigen NY-BR-1 in normal breast, testis and their malignant counterparts
✍ Jean-Philippe Theurillat; Ursina ZΓΌrrer-HΓ€rdi; Zsuzsanna Varga; AndrΓ© Barghorn; πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 French βš– 611 KB

## Abstract NY‐BR‐1 is a differentiation antigen and a potential target for cancer immunotherapy. Its mRNA expression is restricted to breast, testis, prostate and breast cancer by RT‐PCR. In this study, we correlated NY‐BR‐1 protein and mRNA expression on tissue microarrays of mammary, prostatic a

The differentiation antigen NY-BR-1 is a
The differentiation antigen NY-BR-1 is a potential target for antibody-based therapies in breast cancer
✍ Inka Seil; Claudia Frei; Holger SΓΌltmann; Shirley K. Knauer; Knut Engels; Elke J πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 French βš– 976 KB

## Abstract Antibody‐based cancer immunotherapy relies on the identification and characterization of target antigens and the development of potent antibodies recognizing the target. Here we report the expression analysis and molecular characterization of the differentiation antigen NY‐BR‐1, which w

Expression of the SART-1 tumor rejection
Expression of the SART-1 tumor rejection antigen in breast cancer
✍ Mayumi Kawamoto; Shigeki Shichijo; Yasuhisa Imai; Toshihiko Imaizumi; Toshihiro πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 French βš– 127 KB πŸ‘ 2 views

We investigated in breast cancers the expression of the SART-1 gene encoding tumor rejection antigens. SART-1 mRNA was expressed in all of the samples tested. The SART-1 800 antigen was detectable in 20 of 50 (40%) breast cancer tissues and all breast cancer cell lines tested, but not in normal brea

Expression of the tumor-rejection antige
Expression of the tumor-rejection antigen SART1 in brain tumors
✍ Toshihiro Imaizumi; Terukazu Kuramoto; Kazuko Matsunaga; Shigeki Shichijo; Shige πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 French βš– 156 KB πŸ‘ 2 views

We have reported a tumor-rejection antigen, SART1 259 , possessing tumor epitopes capable of inducing cytotoxic T lymphocytes (CTLs) in epithelial-cancer patients. This study investigated the expression of SART1 259 antigen in brain tumors, to explore for a potential molecule for use in specific imm